Rapid risk assessment: Emergence of resistance to ceftazidime-avibactam in carbapenem-resistant Enterobacteriaceae

Risk assessment
Cite:
Citation Link

European Centre for Disease Prevention and Control. Emergence of resistance to ceftazidime-avibactam in carbapenem-resistant Enterobacteriaceae – 12 June 2018.  Stockholm; ECDC; 2018. 

Copy citation to clipboard

This risk assessment will discuss CAZ-AVI resistance in brief, review the recent literature reporting resistance of CRE to CAZ-AVI, and assess the risk for the EU/EEA countries. It will outline options for appropriate detection of resistance and the correct and timely implementation of IPC measures to prevent spread of these highly resistant organisms within healthcare settings and across borders.

Related content

Publication

Rapid risk assessment: Outbreak of carbapenemase-producing Enterobacterales in Lithuania, 2019

Risk assessment -

Data

Target 2.4 - Antimicrobial drug resistance characterisation and monitoring 2018

Map -

Publication

European surveillance of Clostridioides (Clostridium) difficile infections - surveillance protocol version 2.4

Technical guidance, Protocol -

Publication

External quality assessment of laboratory performance – European Antimicrobial Resistance Surveillance Network (EARS-Net), 2018

External quality assessment -

Publication

Survey of healthcare workers’ knowledge, attitudes and behaviours on antibiotics, antibiotic use and antibiotic resistance in the EU/EEA

Technical report -